<PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">39442491</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1464-3391</ISSN><JournalIssue CitedMedium="Internet"><Volume>114</Volume><PubDate><Year>2024</Year><Month>Oct</Month><Day>11</Day></PubDate></JournalIssue><Title>Bioorganic &amp; medicinal chemistry</Title><ISOAbbreviation>Bioorg Med Chem</ISOAbbreviation></Journal><ArticleTitle>Structure-guided design and photochemical synthesis of new carbamo(dithioperoxo)thioates with improved potencies to SARS-CoV-2 3CL<sup>pro</sup>.</ArticleTitle><Pagination><StartPage>117940</StartPage><MedlinePgn>117940</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.bmc.2024.117940</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0968-0896(24)00354-7</ELocationID><Abstract><AbstractText>The COVID-19 pandemic, caused by the SARS-CoV-2 virus, has triggered a protracted global pandemic from 2019 to 2022, and posed a significant threat to human health. One of the non-structural proteins 3CL<sup>pro</sup> of SARS-CoV-2 is considered as a validated target for the development of inhibitors against the virus. Disulfiram has been reported as a covalent inhibitor of 3CL<sup>pro</sup>; however, its structure lacks bonding site with active pockets of 3CL<sup>pro</sup> and its highly symmetric structure doesn't match well with the irregular cavity of the active center, limiting its therapeutic applications. To enhance their affinity for the 3CL<sup>pro</sup> target, in this study, two kinds of disulfiram derivatives, designed based on the reevaluation and optimization of disulfiram, have been synthesized through photoredox chemistry, and the novel carbamo(dithioperoxo)thioates 4g-m were found to display 5-17 folds potency against SARS-CoV-2 3CL<sup>pro</sup> compared to the parent disulfiram, with resulting half-maximal inhibitory concentration (IC<sub>50</sub>) values ranging from 0.14-0.47 μM. Carbamo(dithioperoxo)thioates 4i containing a 4-hydroxy piperidine and a 4-trifluoromethyl phenyl ring, was identified as the most potent inhibitor to both 3CL<sup>pro</sup> (IC<sub>50</sub> = 0.14 μM) and PL<sup>pro</sup> (IC<sub>50</sub> = 0.04 μM). Furthermore, molecular dynamics simulations, binding free energy analysis and mass analysis were performed and provided insights on the stability, conformational behavior, and interactions of 4g with 3CL<sup>pro</sup>. The green synthetic methodology, the privileged carbamo(dithioperoxo)thioate scaffold, and the molecular mechanisms presented might serve as a useful system for the further discovery of highly potent inhibitors targeting SARS-CoV-2 3CL<sup>pro</sup>.</AbstractText><CopyrightInformation>Copyright © 2024 Elsevier Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Yin</LastName><ForeName>De-Hang</ForeName><Initials>DH</Initials><AffiliationInfo><Affiliation>College of Chemistry and Chemical Engineering, Taiyuan University of Technology, Taiyuan 030024, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xin</LastName><ForeName>Jie</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>The People's Hospital of Feicheng, Feicheng 271600, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Shizhao</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>School of Chinese Materia Medica, Nanjing University of Chinese Medicine, Nanjing 210023, China; Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Shuai-Shuai</ForeName><Initials>SS</Initials><AffiliationInfo><Affiliation>College of Chemistry and Chemical Engineering, Taiyuan University of Technology, Taiyuan 030024, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Zi-Ying</ForeName><Initials>ZY</Initials><AffiliationInfo><Affiliation>College of Chemistry and Chemical Engineering, Taiyuan University of Technology, Taiyuan 030024, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meng</LastName><ForeName>Jin-Xi</ForeName><Initials>JX</Initials><AffiliationInfo><Affiliation>College of Chemistry and Chemical Engineering, Taiyuan University of Technology, Taiyuan 030024, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Yue-Chi</ForeName><Initials>YC</Initials><AffiliationInfo><Affiliation>College of Chemistry and Chemical Engineering, Taiyuan University of Technology, Taiyuan 030024, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yin</LastName><ForeName>Bing-Qian</ForeName><Initials>BQ</Initials><AffiliationInfo><Affiliation>College of Chemistry and Chemical Engineering, Taiyuan University of Technology, Taiyuan 030024, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Cheng</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>College of Chemistry and Chemical Engineering, Taiyuan University of Technology, Taiyuan 030024, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Jia</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>School of Chinese Materia Medica, Nanjing University of Chinese Medicine, Nanjing 210023, China; Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gao</LastName><ForeName>Hang</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>College of Chemistry and Chemical Engineering, Taiyuan University of Technology, Taiyuan 030024, China. Electronic address: hanggao@tyut.edu.cn.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tian</LastName><ForeName>Jun</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>College of Chemistry and Chemical Engineering, Taiyuan University of Technology, Taiyuan 030024, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gao</LastName><ForeName>Wen-Chao</ForeName><Initials>WC</Initials><AffiliationInfo><Affiliation>College of Chemistry and Chemical Engineering, Taiyuan University of Technology, Taiyuan 030024, China. Electronic address: gaowenchao@tyut.edu.cn.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Bioorg Med Chem</MedlineTA><NlmUniqueID>9413298</NlmUniqueID><ISSNLinking>0968-0896</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">3CL(pro)</Keyword><Keyword MajorTopicYN="N">Carbamo(dithioperoxo)thioates</Keyword><Keyword MajorTopicYN="N">Disulfiram</Keyword><Keyword MajorTopicYN="N">Photochemistry</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword></KeywordList><CoiStatement>Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>6</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>9</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>10</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>24</Day><Hour>0</Hour><Minute>22</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>24</Day><Hour>0</Hour><Minute>22</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>23</Day><Hour>18</Hour><Minute>9</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39442491</ArticleId><ArticleId IdType="doi">10.1016/j.bmc.2024.117940</ArticleId><ArticleId IdType="pii">S0968-0896(24)00354-7</ArticleId></ArticleIdList></PubmedData></PubmedArticle>